SK285944B6 - Pamoátová soľ olanzapínu a jej solváty - Google Patents

Pamoátová soľ olanzapínu a jej solváty Download PDF

Info

Publication number
SK285944B6
SK285944B6 SK416-2001A SK4162001A SK285944B6 SK 285944 B6 SK285944 B6 SK 285944B6 SK 4162001 A SK4162001 A SK 4162001A SK 285944 B6 SK285944 B6 SK 285944B6
Authority
SK
Slovakia
Prior art keywords
olanzapine
pamoate
pva
spacing
miglyol
Prior art date
Application number
SK416-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK4162001A3 (en
Inventor
Charles Arthur Bunnell
Thomas Harry Ferguson
Barry Arnold Hendriksen
Manuel Vicente Sanchez-Felix
David Edward Tupper
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SK4162001A3 publication Critical patent/SK4162001A3/sk
Publication of SK285944B6 publication Critical patent/SK285944B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK416-2001A 1998-09-30 1999-03-24 Pamoátová soľ olanzapínu a jej solváty SK285944B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation
PCT/US1999/006417 WO2000018408A1 (en) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Publications (2)

Publication Number Publication Date
SK4162001A3 SK4162001A3 (en) 2002-03-05
SK285944B6 true SK285944B6 (sk) 2007-11-02

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
SK416-2001A SK285944B6 (sk) 1998-09-30 1999-03-24 Pamoátová soľ olanzapínu a jej solváty

Country Status (28)

Country Link
EP (1) EP1119359B1 (de)
JP (1) JP4551988B2 (de)
CN (1) CN1146422C (de)
AT (2) ATE267602T1 (de)
AU (1) AU759751B2 (de)
BR (1) BR9914156A (de)
CA (1) CA2344873A1 (de)
CZ (1) CZ302367B6 (de)
DE (2) DE69935873T2 (de)
DK (2) DK1119359T3 (de)
EA (1) EA002580B1 (de)
ES (2) ES2221376T3 (de)
GE (1) GEP20094818B (de)
HK (1) HK1041199B (de)
HR (1) HRP20010238B1 (de)
HU (1) HU227400B1 (de)
ID (1) ID29574A (de)
IL (2) IL141766A0 (de)
MY (1) MY126476A (de)
NO (1) NO328243B1 (de)
NZ (1) NZ510208A (de)
PL (1) PL196821B1 (de)
PT (2) PT1468689E (de)
SK (1) SK285944B6 (de)
TR (1) TR200100885T2 (de)
TW (1) TW577890B (de)
UA (1) UA66872C2 (de)
WO (1) WO2000018408A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
CA2395774C (en) * 1999-12-28 2009-09-15 Cipla Limited New polymorphic forms of olanzapine
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
JP5324098B2 (ja) * 2004-11-16 2013-10-23 アルケルメス ファーマ アイルランド リミテッド 注射可能なナノ粒子のオランザピン製剤
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
CN103249416B (zh) 2010-10-18 2019-06-04 大日本住友制药株式会社 注射用缓释制剂
WO2014125500A1 (en) 2013-02-13 2014-08-21 Neuland Laboratories Limited A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
CA3057438A1 (en) 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
PT669128E (pt) * 1992-11-17 2000-06-30 Yoshitomi Pharmaceutical Micro-esfera de libertacao sustentada contendo antipsicoticos e processo para produzir a mesma
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
HU226167B1 (hu) * 1996-09-23 2008-05-28 Lilly Co Eli Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
AU752552C (en) * 1997-09-30 2003-09-11 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation

Also Published As

Publication number Publication date
EP1119359B1 (de) 2004-05-26
BR9914156A (pt) 2001-06-26
CZ20011149A3 (cs) 2002-01-16
DE69917663D1 (de) 2004-07-01
NO20011583L (no) 2001-03-28
GEP20094818B (en) 2009-11-10
EP1119359A1 (de) 2001-08-01
PL346981A1 (en) 2002-03-11
DE69935873T2 (de) 2008-01-10
NZ510208A (en) 2003-04-29
EP1119359A4 (de) 2001-12-19
PT1119359E (pt) 2004-08-31
CN1146422C (zh) 2004-04-21
EA002580B1 (ru) 2002-06-27
HU227400B1 (en) 2011-05-30
ES2221376T3 (es) 2004-12-16
NO328243B1 (no) 2010-01-11
HK1041199B (zh) 2005-03-18
CZ302367B6 (cs) 2011-04-13
HRP20010238B1 (en) 2006-05-31
HUP0103636A2 (hu) 2002-01-28
DE69917663T2 (de) 2005-05-25
IL141766A (en) 2006-12-31
ATE267602T1 (de) 2004-06-15
HUP0103636A3 (en) 2003-05-28
DK1119359T3 (da) 2004-08-16
DE69935873D1 (de) 2007-05-31
MY126476A (en) 2006-10-31
JP2002525330A (ja) 2002-08-13
NO20011583D0 (no) 2001-03-28
CA2344873A1 (en) 2000-04-06
ATE359793T1 (de) 2007-05-15
HRP20010238A2 (en) 2002-04-30
DK1468689T3 (da) 2007-08-13
IL141766A0 (en) 2002-03-10
JP4551988B2 (ja) 2010-09-29
HK1041199A1 (en) 2002-07-05
AU3362799A (en) 2000-04-17
SK4162001A3 (en) 2002-03-05
PL196821B1 (pl) 2008-02-29
TR200100885T2 (tr) 2001-08-21
EA200100406A1 (ru) 2001-10-22
CN1320038A (zh) 2001-10-31
TW577890B (en) 2004-03-01
AU759751B2 (en) 2003-05-01
WO2000018408A1 (en) 2000-04-06
ES2285294T3 (es) 2007-11-16
ID29574A (id) 2001-09-06
UA66872C2 (uk) 2004-06-15
PT1468689E (pt) 2007-07-09

Similar Documents

Publication Publication Date Title
US6169084B1 (en) 2-methyl-thieno-benzodiazepine formulation
SK285944B6 (sk) Pamoátová soľ olanzapínu a jej solváty
US6617321B2 (en) 2-methyl-thieno-benzodiazepine formulation
EP1468689B1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
MXPA01003288A (en) 2-methyl-thieno-benzodiazepine formulation
MXPA00003040A (en) 2-methyl-thieno-benzodiazepine formulation

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20190324